Established in 1923, Diosynth Biotechnology operates a manufacturing plant that utilizes cell culture and microbial production processes to manufacture drugs. The company offers a range of recombinant therapeutic proteins and vaccines for preclinical, clinical and commercial purposes. Its analytical development team works on various techniques, such as DNA sequencing, biophysical characterization, capillary electrophoresis and mass spectrometry. Diosynth Biotechnology manufactures products using mammalian, insect and microbial expression systems. In addition, the company s cell culture development technology utilizes hybridomas, murine myelomas and human cell lines. It undertakes real time stability studies for products, intermediates and reference standards. Diosynth Biotechnology maintains a location in Morrisville, N.C.